Company Filing History:
Years Active: 2020-2024
Title: **Innovative Contributions of Inventor Ranjan Batra**
Introduction
Ranjan Batra, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of RNA biology. With a total of two patents to his name, Batra's work reflects his commitment to advancing scientific knowledge and therapeutic applications.
Latest Patents
Ranjan Batra's latest patents showcase cutting-edge research in engineered RNA systems. The first patent, titled "Compositions and methods comprising engineered short nuclear RNA (snRNA)", discloses innovative snRNA systems that include engineered stem loops. These systems hold potential for various applications in gene regulation and therapeutic strategies. His second patent, "RNA-targeting fusion protein compositions and methods for use," describes compositions that include a sequence encoding a fusion protein comprising two distinct RNA-binding polypeptides. This invention is particularly noteworthy as it outlines methods of treating genetic and epigenetic diseases or disorders, highlighting Batra's focus on addressing critical health challenges.
Career Highlights
Ranjan Batra has worked with prominent companies in the biotechnology sector, including Locana, Inc. and Locanabio, Inc. These affiliations have allowed him to translate his innovative concepts into practical applications that advance medical research and treatment options.
Collaborations
Throughout his career, Batra has collaborated with esteemed colleagues such as David A. Nelles and Eugene Yeo. These partnerships have enriched his research endeavors, fostering an environment of shared knowledge and innovation that is essential in the rapidly evolving field of molecular biology.
Conclusion
Ranjan Batra's contributions to the field of RNA research through his patents and collaborations exemplify his role as a leading inventor in the biotechnology arena. His work not only enhances our understanding of RNA mechanisms but also paves the way for developing novel therapies for genetic and epigenetic disorders. As he continues his innovative journey, the scientific community eagerly anticipates his future contributions.